tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IRON Stock Latest News

FDA review process for accelerated approval narrows, less predictable, WSJ says
The FlyFDA review process for accelerated approval narrows, less predictable, WSJ says
12d ago
CAPR
IRON
Disc Medicine price target raised to $79 from $78 at Wells Fargo
PremiumThe Fly
Disc Medicine price target raised to $79 from $78 at Wells Fargo
13d ago
IRON
Disc Medicine Implements Restructuring Following FDA Response
PremiumCompany Announcements
Disc Medicine Implements Restructuring Following FDA Response
16d ago
8K
IRON
Disc Medicine price target lowered to $83 from $114 at Truist
PremiumThe Fly
Disc Medicine price target lowered to $83 from $114 at Truist
16d ago
IRON
Disc Medicine price target raised to $111 from $110 at Stifel
PremiumThe Fly
Disc Medicine price target raised to $111 from $110 at Stifel
16d ago
IRON
Disc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
PremiumRatingsDisc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
16d ago
IRON
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
Premium
Ratings
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
17d ago
IRON
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
Premium
The Fly
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
17d ago
IRON
Disc Medicine’s RALLY-IBD Trial Puts a Spotlight on Anemia Relief in IBD Patients
PremiumCompany Announcements
Disc Medicine’s RALLY-IBD Trial Puts a Spotlight on Anemia Relief in IBD Patients
18d ago
IRON
Disc Medicine price target lowered to $88 from $110 at Wedbush
PremiumThe Fly
Disc Medicine price target lowered to $88 from $110 at Wedbush
26d ago
IRON
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
PremiumThe Fly
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
26d ago
IRON
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
PremiumThe Fly
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
26d ago
IRON
Disc Medicine price target lowered to $110 from $125 at Stifel
PremiumThe FlyDisc Medicine price target lowered to $110 from $125 at Stifel
26d ago
IRON
Disc Medicine price target lowered to $100 from $120 at BMO Capital
Premium
The Fly
Disc Medicine price target lowered to $100 from $120 at BMO Capital
26d ago
IRON
Disc Medicine Addresses FDA Rejection of Bitopertin Filing
Premium
Company Announcements
Disc Medicine Addresses FDA Rejection of Bitopertin Filing
26d ago
8K
IRON
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
PremiumRatings
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
26d ago
IRON
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
PremiumThe Fly
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
27d ago
IRON
Disc Medicine Receives FDA Complete Response on Bitopertin
PremiumCompany Announcements
Disc Medicine Receives FDA Complete Response on Bitopertin
30d ago
8K
IRON
Disc Medicine off lows after saying FDA issue ‘readily addressable’
PremiumThe Fly
Disc Medicine off lows after saying FDA issue ‘readily addressable’
30d ago
IRON
Disc Medicine down 32% to $49 after confirming rejection letter from FDA
PremiumThe FlyDisc Medicine down 32% to $49 after confirming rejection letter from FDA
30d ago
IRON
Disc Medicine confirms complete response letter from FDA for bitopertin
Premium
The Fly
Disc Medicine confirms complete response letter from FDA for bitopertin
30d ago
IRON
Disc Medicine says issue raised by FDA ‘readily addressable’
Premium
The Fly
Disc Medicine says issue raised by FDA ‘readily addressable’
30d ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >